title: Recombinant human erythropoietin treatment reverses hepatic iron overload in hemodialysis patients.
authors.forename: Y
authors.initials: Y
authors.lastname: Berland
authors.forename: M
authors.initials: M
authors.lastname: Baz
authors.forename: D
authors.initials: D
authors.lastname: Di Stefano
authors.forename: T
authors.initials: T
authors.lastname: Merzouk
authors.forename: J M
authors.initials: JM
authors.lastname: Bartoli
authors.forename: B
authors.initials: B
authors.lastname: Dussol
authors.forename: M
authors.initials: M
authors.lastname: Kasbarian
mesh_terms: D000328:Adult; D000368:Aged; D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007501:Iron / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D065227:Transfusion Reaction
chemical_list: D004921:Erythropoietin; D007501:Iron